aldosterone has been researched along with Compensatory Hyperinsulinemia in 17 studies
Compensatory Hyperinsulinemia: A GLUCOSE-induced HYPERINSULINEMIA, a marker of insulin-resistant state. It is a mechanism to compensate for reduced sensitivity to insulin.
Excerpt | Relevance | Reference |
---|---|---|
"Chronic HFD exposure further promoted hyperinsulinemia in ASKO mice that contributed to visceral fat accumulation accompanied by reduced lipolysis, thermogenic reprogramming, and the absence of weight-gain-related EE increases." | 5.48 | Aldosterone deficiency in mice burdens respiration and accentuates diet-induced hyperinsulinemia and obesity. ( Faresse, N; Henneberg, M; Langhans, W; Liao, WH; Odermatt, A; Pacheco Lopez, G; Steuer, AE; Suendermann, C, 2018) |
"To measure the effects of hyperinsulinemia on serum electrolyte status and associated hormones, and on serum free fatty acid (FFA) concentrations, in patients with essential hypertension." | 5.31 | Serum aldosterone changes during hyperinsulinemia are correlated to body mass index and insulin sensitivity in patients with essential hypertension. ( Haenni, A; Lind, L; Lithell, H; Reneland, R, 2001) |
"These results demonstrates that hypertension and insulin resistance induced by COC is associated with increased cardiac RAS and PAI-1 gene expression, which is likely to be through corticosterone-dependent but not aldosterone-dependent mechanism." | 3.85 | Activation of cardiac renin-angiotensin system and plasminogen activator inhibitor-1 gene expressions in oral contraceptive-induced cardiometabolic disorder. ( Kim, IK; Olatunji, LA; Seok, YM; Usman, TO, 2017) |
" Therefore, food intake and weight gain were measured in obese adrenalectomized VMH-lesioned rats given continuous infusion of various doses of either a type I-receptor agonist (aldosterone), a type II-receptor agonist (RU-28362), or several combination doses." | 3.69 | Relative contribution of type I and II corticosterone receptors in VMH lesion-induced obesity and hyperinsulinemia. ( Devenport, LD; Stith, RD; Thomas, TL, 1994) |
"In both groups, hyperinsulinemia caused a decrease in blood volume (0." | 2.70 | Defective regulation and action of atrial natriuretic peptide in type 2 diabetes. ( Baldi, S; Catalano, C; Ferrannini, E; Nannipieri, M; Prontera, T; Seghieri, G, 2002) |
"Obesity is strongly associated with hypertension and cardiovascular disease." | 2.43 | Obesity-associated hypertension: new insights into mechanisms. ( Correia, ML; Haynes, WG; Mark, AL; Rahmouni, K, 2005) |
"Chronic HFD exposure further promoted hyperinsulinemia in ASKO mice that contributed to visceral fat accumulation accompanied by reduced lipolysis, thermogenic reprogramming, and the absence of weight-gain-related EE increases." | 1.48 | Aldosterone deficiency in mice burdens respiration and accentuates diet-induced hyperinsulinemia and obesity. ( Faresse, N; Henneberg, M; Langhans, W; Liao, WH; Odermatt, A; Pacheco Lopez, G; Steuer, AE; Suendermann, C, 2018) |
"(1) Within a normotensive range, hyperinsulinemia and/or insulin resistance influence daily BP variation more than obesity does, suggesting a pivotal role of insulin on BP control in PCOS; (2) altered insulinemic state and ABPM-derived higher nighttime BP and HR may represent early markers to identify PCOS subjects prone to high cardiovascular risk." | 1.46 | Hyperinsulinemia and obese phenotype differently influence blood pressure in young normotensive patients with polycystic ovary syndrome. ( Azzolini, S; Bleve, L; Cà, AD; Fallo, F; Maffei, P; Mioni, R; Turra, J; Vettor, R; Xamin, N, 2017) |
"To measure the effects of hyperinsulinemia on serum electrolyte status and associated hormones, and on serum free fatty acid (FFA) concentrations, in patients with essential hypertension." | 1.31 | Serum aldosterone changes during hyperinsulinemia are correlated to body mass index and insulin sensitivity in patients with essential hypertension. ( Haenni, A; Lind, L; Lithell, H; Reneland, R, 2001) |
"Finally, the magnitude of hyperinsulinemia correlated directly with systolic (r = 0." | 1.28 | Changes in blood pressure, plasma triglyceride and aldosterone concentration, and red cell cation concentration in patients with hyperinsulinemia. ( Battezzati, M; Massarino, F; Mazza, S; Pontremoli, R; Reaven, GM; Tixianello, A; Zavaroni, I, 1991) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (5.88) | 18.7374 |
1990's | 6 (35.29) | 18.2507 |
2000's | 7 (41.18) | 29.6817 |
2010's | 3 (17.65) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Liao, WH | 1 |
Suendermann, C | 1 |
Steuer, AE | 1 |
Pacheco Lopez, G | 1 |
Odermatt, A | 1 |
Faresse, N | 1 |
Henneberg, M | 1 |
Langhans, W | 1 |
Olatunji, LA | 1 |
Usman, TO | 1 |
Seok, YM | 1 |
Kim, IK | 1 |
Mioni, R | 1 |
Cà, AD | 1 |
Turra, J | 1 |
Azzolini, S | 1 |
Xamin, N | 1 |
Bleve, L | 1 |
Maffei, P | 1 |
Vettor, R | 1 |
Fallo, F | 1 |
Rahmouni, K | 1 |
Correia, ML | 1 |
Haynes, WG | 1 |
Mark, AL | 1 |
Colussi, G | 1 |
Catena, C | 1 |
Lapenna, R | 1 |
Nadalini, E | 1 |
Chiuch, A | 1 |
Sechi, LA | 1 |
Perciaccante, A | 1 |
Fiorentini, A | 1 |
Valente, R | 1 |
Di Stefano, A | 1 |
Tubani, L | 1 |
Thomas, TL | 1 |
Devenport, LD | 1 |
Stith, RD | 1 |
Inoue, J | 1 |
Cappuccio, FP | 1 |
Sagnella, GA | 1 |
Markandu, ND | 1 |
Folkerd, EJ | 1 |
Sampson, B | 1 |
Miller, MA | 1 |
Blackwood, AM | 1 |
MacGregor, GA | 1 |
Petrie, JR | 1 |
Morris, AD | 1 |
Ueda, S | 1 |
Small, M | 1 |
Donnelly, R | 1 |
Connell, JM | 1 |
Elliott, HL | 1 |
Haenni, A | 1 |
Reneland, R | 1 |
Lind, L | 2 |
Lithell, H | 2 |
Andronico, G | 1 |
Cottone, S | 1 |
Mangano, MT | 1 |
Ferraro-Mortellaro, R | 1 |
Baiardi, G | 1 |
Grassi, N | 1 |
Ferrara, L | 1 |
Mulé, G | 1 |
Cerasola, G | 1 |
Nannipieri, M | 1 |
Seghieri, G | 1 |
Catalano, C | 1 |
Prontera, T | 1 |
Baldi, S | 1 |
Ferrannini, E | 1 |
Resnick, LM | 1 |
Wide, L | 1 |
Ljunghall, S | 1 |
Pontremoli, R | 1 |
Zavaroni, I | 1 |
Mazza, S | 1 |
Battezzati, M | 1 |
Massarino, F | 1 |
Tixianello, A | 1 |
Reaven, GM | 1 |
Ferriss, JB | 1 |
Rastogi, KS | 1 |
Campbell, J | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
The Role of Aldosterone on Sympathetic Nerve Activity and Insulin Sensitivity[NCT02102243] | Phase 4 | 0 participants (Actual) | Interventional | 2010-11-30 | Withdrawn (stopped due to No longer interested in study topic) | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
3 reviews available for aldosterone and Compensatory Hyperinsulinemia
Article | Year |
---|---|
Obesity-associated hypertension: new insights into mechanisms.
Topics: Adiponectin; Aldosterone; Animals; Appetite; Endothelium, Vascular; Energy Metabolism; Ghrelin; Huma | 2005 |
Cellular calcium and magnesium metabolism in the pathophysiology and treatment of hypertension and related metabolic disorders.
Topics: Aldosterone; Blood Glucose; Blood Pressure; Calcium; Calcium Channel Blockers; Cardiomegaly; Diabete | 1992 |
The causes of raised blood pressure in insulin-dependent and non-insulin-dependent diabetes.
Topics: Aldosterone; Blood Pressure; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Angiopat | 1991 |
3 trials available for aldosterone and Compensatory Hyperinsulinemia
Article | Year |
---|---|
Glucose load and renal sodium handling in mild essential hypertension on different sodium intakes.
Topics: Adolescent; Adult; Aldosterone; C-Peptide; Cross-Over Studies; Diet, Sodium-Restricted; Double-Blind | 1996 |
Trandolapril does not improve insulin sensitivity in patients with hypertension and type 2 diabetes: a double-blind, placebo-controlled crossover trial.
Topics: Adult; Aged; Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Blood Glucose; Blood Pressure; C | 2000 |
Defective regulation and action of atrial natriuretic peptide in type 2 diabetes.
Topics: Adult; Aged; Aldosterone; Atrial Natriuretic Factor; Blood Glucose; Blood Volume; Body Mass Index; D | 2002 |
11 other studies available for aldosterone and Compensatory Hyperinsulinemia
Article | Year |
---|---|
Aldosterone deficiency in mice burdens respiration and accentuates diet-induced hyperinsulinemia and obesity.
Topics: Adipocytes; Aldosterone; Animals; Cytochrome P-450 CYP11B2; Diet, High-Fat; Disease Models, Animal; | 2018 |
Activation of cardiac renin-angiotensin system and plasminogen activator inhibitor-1 gene expressions in oral contraceptive-induced cardiometabolic disorder.
Topics: Aldosterone; Animals; Ataxia Telangiectasia Mutated Proteins; Cardiovascular Diseases; Contraceptive | 2017 |
Hyperinsulinemia and obese phenotype differently influence blood pressure in young normotensive patients with polycystic ovary syndrome.
Topics: Adolescent; Adult; Aldosterone; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Cross-Section | 2017 |
Insulin resistance and hyperinsulinemia are related to plasma aldosterone levels in hypertensive patients.
Topics: Aged; Aldosterone; Cross-Sectional Studies; Female; Glucose; Humans; Hyperinsulinism; Hypertension; | 2007 |
Insulin resistance and hyperinsulinemia are related to plasma aldosterone levels in hypertensive patients: response to Colussi et al.
Topics: Aldosterone; Humans; Hyperinsulinism; Hypertension; Insulin; Insulin Resistance; Reproducibility of | 2007 |
Relative contribution of type I and II corticosterone receptors in VMH lesion-induced obesity and hyperinsulinemia.
Topics: Adrenalectomy; Aldosterone; Androstanols; Animals; Female; Hyperinsulinism; Hyperphagia; Insulin; Ob | 1994 |
Serum aldosterone changes during hyperinsulinemia are correlated to body mass index and insulin sensitivity in patients with essential hypertension.
Topics: Aldosterone; Biomarkers; Blood Glucose; Blood Pressure; Body Mass Index; Calcium; Disease Progressio | 2001 |
Insulin, renin-aldosterone system and blood pressure in obese people.
Topics: Adult; Aldosterone; Blood Pressure; Cross-Sectional Studies; Female; Humans; Hyperinsulinism; Hypert | 2001 |
Metabolic cardiovascular risk factors and the renin-aldosterone system in essential hypertension.
Topics: Adult; Aldosterone; Body Mass Index; Cardiovascular Diseases; Cholesterol, HDL; Creatine; Female; Gl | 1992 |
Changes in blood pressure, plasma triglyceride and aldosterone concentration, and red cell cation concentration in patients with hyperinsulinemia.
Topics: Aldosterone; Atrial Natriuretic Factor; Blood Pressure; Cations; Erythrocyte Count; Erythrocytes; Hu | 1991 |
Effect of growth hormone on cortisone-induced hyperinsulinemia and reduction in pancreatic insulin in the mouse.
Topics: Adenoma, Islet Cell; Aldosterone; Animals; Blood Glucose; Body Weight; Cortisone; Drug Antagonism; E | 1970 |